{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_014109.5:c.6006G>S",
          "cDNA Change": {
            "transcript": "NM_014109.5",
            "ref": "G",
            "alt": "S",
            "position": "6006"
          },
          "Protein Change": {
            "ref": "K",
            "alt": "R",
            "position": "2002"
          },
          "Description in input context": "c.6006G>S (p.K2002R)"
        },
        {
          "HGVS": "NM_014109.5:c.6019C>T",
          "cDNA Change": {
            "transcript": "NM_014109.5",
            "ref": "C",
            "alt": "T",
            "position": "6019"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "S",
            "position": "2007"
          },
          "Description in input context": "c.6019C>T (p.R2007S)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0005412"
  },
  "Experiment Method": [
    {
      "Assay Method": "Over-expression of human LRRK2 alleles in Drosophila",
      "Material used": {
        "Material Source": "Drosophila",
        "Material Name": "Transgenic flies",
        "Description": "Transgenic Drosophila were generated to over-express various human LRRK2 alleles, including wild-type and mutant proteins."
      },
      "Readout type": "Qualitative/Quantitative",
      "Readout description": [
        {
          "Variant": "NM_014109.5:c.6006G>S",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Transgenic flies harboring the G2019S, Y1699C, or G2385R LRRK2 variant exhibited late-onset loss of dopaminergic (DA) neurons."
        },
        {
          "Variant": "NM_014109.5:c.6019C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Transgenic flies harboring the G2019S, Y1699C, or G2385R LRRK2 variant exhibited late-onset loss of dopaminergic (DA) neurons."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple biological replicates were performed to confirm the results."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "Technical replicates were not mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Descriptive statistics were used to analyze the results."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Not specified",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Not specified",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    }
  ]
}